A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone.

Trial Profile

A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Proof-of-Concept Trial to Assess Relief of Meal Induced Heartburn by a Combination of Lansoprazole 15 mg and Antacid Versus Lansoprazole 15 mg and Antacid (Calcium Carbonate and Magnesium Hydroxide) Alone.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Mar 2011

At a glance

  • Drugs Calcium carbonate; Lansoprazole; Magnesium hydroxide
  • Indications Heartburn
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 27 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.
    • 31 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top